Large-scale testing (Phase 3)Study completedNCT00658528
What this trial is testing
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Eisai Inc. 1,061